Depósito Digital de Documentos de la UAB Encontrados 8 registros  La búsqueda tardó 0.03 segundos. 
1.
9 p, 3.7 MB The Genome-wide Methylation Profile of CD4+ T Cells From Individuals With Human Immunodeficiency Virus (HIV) Identifies Distinct Patterns Associated With Disease Progression / Moron-Lopez, Sara (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ; Urrea, Víctor (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ; Dalmau, Judith (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ; Lopez, Miguel (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Puertas, Maria C. (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ; Ouchi, Dan (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ; Gómez Moruno, Antonio (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Passaes, Caroline (Institut Pasteur) ; Mothe, Beatriz (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ; Brander, Christian (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ; Saez-Cirion, Asier (Institut Pasteur) ; Clotet, Bonaventura (Institut Germans Trias i Pujol. Fundació de Lluita Contra la Sida) ; Esteller, M (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Berdasco, Maria (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Martinez-Picado, Javier (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa)
BACKGROUND: Human genetic variation-mostly in the human leukocyte antigen (HLA) and C-C chemokine receptor type 5 (CCR5) regions-explains 25% of the variability in progression of human immunodeficiency virus (HIV) infection. [...]
2021 - 10.1093/cid/ciaa1047
Clinical Infectious Diseases, Vol. 72 Núm. 9 (april 2021) , p. e256-e264  
2.
6 p, 557.9 KB Interferon-γ-Inducible Protein 10 (IP-10) as a Screening Tool to Optimize Human Immunodeficiency Virus RNA Monitoring in Resource-Limited Settings / Pastor Palomo, Lucía (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Casellas, Aina (Institut de Salut Global de Barcelona) ; Rupérez, María (Centro de Investigação em Saúde da Manhiça) ; Carrillo, Jorge (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ; Maculuve, Sonia (Centro de Investigação em Saúde da Manhiça) ; Jairoce, Chenjerai (Centro de Investigação em Saúde da Manhiça) ; Paredes, Roger (Institut Germans Trias i Pujol. Fundació de Lluita Contra la Sida) ; Blanco, Julià (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ; Naniche, Denise (Centro de Investigação em Saúde da Manhiça) ; Universitat Autònoma de Barcelona
Interferon-γ-inducible protein-10 is an affordable and easily quantifiable biomarker that can be used to accurately screen individuals on antiretroviral treatment (ART) for detectable viremia, optimizing the use of costly viral load determinations required to monitor ART in low-income countries. [...]
2017 - 10.1093/cid/cix600
Clinical Infectious Diseases, Vol. 65 (july 2017) , p. 1670-1675  
3.
10 p, 10.2 MB Cross-transmission Is Not the Source of New Mycobacterium abscessus Infections in a Multicenter Cohort of Cystic Fibrosis Patients / Doyle, Ronan M (National Institute for Health Research) ; Rubio, Marc (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Dixon, Garth (National Institute for Health Research) ; Hartley, John (National Institute for Health Research) ; Klein, Nigel (University College London) ; Coll Figa, Pedro (Universitat Autònoma de Barcelona. Departament de Genètica i de Microbiologia) ; Harris, Kathryn A (National Institute for Health Research)
Mycobacterium abscessus is an extensively drug-resistant pathogen that causes pulmonary disease, particularly in cystic fibrosis (CF) patients. Identifying direct patient-to-patient transmission of M. [...]
2019 - 10.1093/cid/ciz526
Clinical Infectious Diseases, Vol. 70, Issue 9 (May 2019) , p. 1855-1864  
4.
9 p, 1.7 MB Switching From a Protease Inhibitor-based Regimen to a Dolutegravir-based Regimen : A Randomized Clinical Trial to Determine the Effect on Peripheral Blood and Ileum Biopsies From Antiretroviral Therapy-suppressed Human Immunodeficiency Virus-infected Individuals / Moron-Lopez, Sara (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ; Navarro, Jordi (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Jimenez, Montse (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ; Rutsaert, Sofie (Universitair Ziekenhuis Gent) ; Urrea, Víctor (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ; Puertas, Maria C (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ; Torrella Domingo, Adriana (Hospital Universitari Vall d'Hebron) ; De Clercq, Laura (Universitair Ziekenhuis Gent) ; Ribas, Bibiana Planas (Hospital Universitari Vall d'Hebron) ; Gálvez, Cristina (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ; Salgado, Maria (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ; Vandekerckhove, Linos (Universitair Ziekenhuis Gent) ; Blanco, Julià (Universitat de Vic - Universitat Central de Catalunya) ; Crespo, Manel (Infectious Diseases Unit, Internal Medicine Department, Complexo Hospitalario Universitario de Vigo, Instituto de Investigación Sanitaria Galicia Sur) ; Martinez-Picado, Javier (Catalan Institution for Research and Advanced Studies) ; Universitat Autònoma de Barcelona
Optimization of combination antiretroviral therapy (cART) can impact the human immunodeficiency virus (HIV) reservoir. We evaluated the effect on the HIV reservoir in peripheral blood and ileum biopsies in patients switching from boosted protease inhibitor (PI/r)-based therapy to dolutegravir (DTG)-based therapy. [...]
2018 - 10.1093/cid/ciy1095
Clinical Infectious Diseases, Vol. 69 (december 2018) , p. 1320-1328  
5.
8 p, 458.1 KB Is it possible to prevent recurrent vulvovaginitis? The role of Lactobacillus plantarum I1001 (CECT7504) / Palacios, S. (Instituto Palacios de Salud y Medicina de la Mujer) ; Espadaler Mazo, Jordi (Universitat Autònoma de Barcelona) ; Fernández-Moya, J. M. (Instituto de Medicina EGR) ; Prieto, C. (Gynea Laboratorios) ; Salas, N. (Instituto Palacios de Salud y Medicina de la Mujer)
2016 - 10.1007/s10096-016-2715-8
European Journal of Clinical Microbiology & Infectious Diseases, Vol. 35 (july 2016) , p. 1701-1708  
6.
8 p, 539.3 KB Effectiveness of sequential intravenous-to-oral antibiotic switch therapy in hospitalized patients with gram-positive infection : the SEQUENCE cohort study / Rodriguez-Pardo, D. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Pigrau, C. (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Campany, D. (Hospital Universitari Vall d'Hebron) ; Diaz-Brito, V. (Department of Internal Medicine, Parc Sanitari Sant Joan de Déu, Sant Boi de Llobregat, Spain) ; Morata, L. (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; de Diego, I. C. (Hospital Arnau de Vilanova (Lleida, Catalunya)) ; Sorlí, L. (Institut Hospital del Mar d'Investigacions Mèdiques) ; Iftimie, S. (Hospital Universitari Sant Joan de Reus (Tarragona)) ; Pérez-Vidal, Rafel (Hospital Sant Joan de Déu (Manresa)) ; García-Pardo, Graciano (Hospital Universitari Joan XXIII de Tarragona) ; Larrainzar-Coghen, T. (Hospital Universitari Vall d'Hebron) ; Almirante Gragera, Benito (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona
Switching from intravenous to oral antibiotic therapy may improve inpatient management and reduce hospital stays and the complications of intravenous treatment. We aimed to assess the effectiveness of intravenous-to-oral antibiotic switch therapy and an early discharge algorithm in hospitalized patients with gram-positive infection. [...]
2016 - 10.1007/s10096-016-2661-5
European Journal of Clinical Microbiology & Infectious Diseases, Vol. 35 (may 2016) , p. 1269-1276  
7.
7 p, 259.3 KB Mortality According to CD4 Count at Start of Combination Antiretroviral Therapy Among HIV-infected Patients Followed for up to 15 Years After Start of Treatment : Collaborative Cohort Study / May, Margaret T. ; Vehreschild, Jorg-Janne ; Trickey, Adam ; Obel, Niels ; Reiss, Peter ; Bonnet, Fabrice ; Mary-Krause, Murielle ; Samji, Hasina ; Cavassini, Matthias ; Gill, Michael John ; Shepherd, Leah C. ; Crane, Heidi ; D'Arminio Monforte, Antonella ; Burkholder, Greer A. ; Johnson, Margaret M. ; Sobrino-Vegas, Paz ; Domingo, Pere (Domingo Pedrol) ; Zangerle, Robert (Universitat Autònoma de Barcelona. Departament de Medicina) ; Justice, Amy C. ; Sterling, Timothy R. ; Miró, José M. ; Sterne, Jonathan A. C.
The strong association of CD4 count at start of combination therapy with subsequent survival in HIV-infected patients diminished during the first 5 years of treatment. After 5 years, lower baseline CD4 counts were not associated with higher mortality. [...]
2016 - 10.1093/cid/ciw183
Clinical Infectious Diseases, Vol. 62 (march 2016) , p. 1571-1577  
8.
10 p, 473.8 KB Establishment and Replenishment of the Viral Reservoir in Perinatally HIV-1-infected Children Initiating Very Early Antiretroviral Therapy / Martínez-Bonet, Marta (Hospital General Universitario Gregorio Marañón) ; Puertas, Maria Carmen (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ; Fortuny Guasch, Claudia (Hospital Sant Joan de Déu (Manresa)) ; Ouchi, Dan (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ; Mellado, Maria José (Hospital Universitario infantil La Paz (Madrid)) ; Rojo, Pablo (Hospital Universitario 12 de Octubre (Madrid)) ; Noguera-Julian, Antoni (Hospital Sant Joan de Déu (Manresa)) ; Muñoz-Fernández, Ma Angeles (Hospital General Universitario Gregorio Marañón) ; Martinez-Picado, Javier (Institució Catalana de Recerca i Estudis Avançats) ; Universitat Autònoma de Barcelona
Initiation of combined antiretroviral therapy within the first 12 weeks of life in vertically human immunodeficiency virus type 1-infected children favors the establishment of low-level proviral reservoirs. [...]
2015 - 10.1093/cid/civ456
Clinical Infectious Diseases, Vol. 61 (june 2015) , p. 1169-1178  

¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.